Safety and rapid efficacy of guideline-based gender affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.

CONCLUSIONS: Gender affirming hormone therapy in accordance with current clinical-practice guidelines is efficient and safe. PMID: 31751300 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31751300?dopt=Abstract

Source: European Journal of Endocrinology - October 31, 2019 Category: Endocrinology Authors: Meyer G, Mayer M, Mondorf A, Fluegel AK, Herrmann E, Bojunga J Tags: Eur J Endocrinol Source Type: research